Use of Molecular testing prior to first-line Erlotinib Therapy among medicare patients with stage IV non-small Cell Lung Cancer
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1280
https://www.valueinhealthjournal.com/article/S1098-3015(15)01337-6/fulltext
Title :
Use of Molecular testing prior to first-line Erlotinib Therapy among medicare patients with stage IV non-small Cell Lung Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01337-6&doi=10.1016/j.jval.2015.03.1280
First page :
A220
Section Title :
Cancer
Open access? :
No
Section Order :
744